Stroke and cerebrovascular diseases represent a significant public health challenge, affecting millions of individuals worldwide and posing a substantial burden on healthcare systems. These conditions arise from disruptions in blood flow to the brain, leading to a cascade of events that can result in devastating neurological deficits and, in severe cases, death. Stroke, the most common cerebrovascular event, occurs when blood flow to a part of the brain is obstructed, either by a blood clot (ischemic stroke) or ruptured blood vessel (hemorrhagic stroke). The consequences of stroke can be profound, ranging from paralysis and speech impairment to cognitive dysfunction and emotional disturbances. Beyond stroke, cerebrovascular diseases encompass a spectrum of conditions, including transient ischemic attacks (TIAs), cerebral aneurysms, arteriovenous malformations (AVMs), and carotid artery stenosis. These conditions often share common risk factors, such as hypertension, diabetes, smoking, obesity, and sedentary lifestyle. Early diagnosis and intervention are paramount in managing stroke and cerebrovascular diseases to mitigate brain damage and prevent long-term disability. Treatment strategies may include thrombolytic therapy to dissolve blood clots, mechanical thrombectomy to remove obstructing clots from blood vessels, and surgical interventions such as carotid endarterectomy or stenting to reestablish circulation in constricted or obstructed arteries.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom